Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Clinical trial NCT02526524 · COMPLETED
Trial details
- NCT number
- NCT02526524
- Sponsor
- Elcelyx Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-09-01
- Enrollment
- 571
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.